-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-U.S. FDA Approves Tecvayli® In Combination With Darzalex Faspro® For Relapsed/Refractory Multiple Myeloma

Reuters·03/06/2026 13:00:24

Please log in to view news